No Data
No Data
Iovance Biotherapeutics Call Volume Above Normal and Directionally Bullish
Iovance Biotherapeutics Grants Inducement Stock Options and Restricted Stock Units to New Chief Commercial Officer
Press Release: Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer
Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer
Truist Financial Initiates Iovance Biotherapeutics(IOVA.US) With Buy Rating
Iovance Biotherapeutics Insiders Added US$48.3m Of Stock To Their Holdings